The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Unbranded fictitious patient profiles following guidelines?
Claims & Support/References for Claims
1
Posts
1
Posters
21
Views
-
Hello PAAB, wondering if a fictitious, unbranded patient would need to follow guidelines in terms of their treatment journey? In real life, HCPs do not always follow guidelines.
i.e., if guidelines recommend Product X as first-line treatment, then Product Y as second-line treatment in refractory patients; could an unbranded patient profile show a patient being initiated on Product Y? Thank you!